Toplash vs GrandeLASH-MD: Which Eyelash Serum Should You Buy?

The short version

These are two of the most talked-about serums in the US, but they take opposite approaches. Toplash is a peptide serum with no prostaglandin analog — strong conditioning support, a clean safety profile, and by far the lower price. GrandeLASH-MD uses a prostaglandin analog (isopropyl cloprostenate) to drive faster, more dramatic growth, at the cost of a real side-effect profile and a higher monthly spend.

Safety is the deciding factor

This is the crux of the decision. GrandeLASH-MD’s isopropyl cloprostenate is associated with eyelid darkening, redness, and — in some users — permanent iris darkening and orbital fat atrophy. Toplash’s peptide formula carries none of those risks, which is why it’s our overall pick for a general audience. (See our methodology for how we weight safety against efficacy.)

Results and what to expect

GrandeLASH-MD’s prostaglandin analog tends to produce faster, more dramatic length — that’s the upside of the ingredient class, and it’s backed by a large, satisfied user base. Toplash works more gradually, as peptide serums do, but it does so without the eye-related risks and at a fraction of the cost.

Price

It isn’t close. Toplash runs under about $10 per month, while GrandeLASH-MD costs noticeably more for a comparable supply. For most shoppers, Toplash delivers the better value by a wide margin.

Bottom line

For most people, Toplash is the smarter buy: a clean safety profile, credible EU manufacturing, and the lowest price in our ranking. Reserve GrandeLASH-MD for experienced users chasing maximum length who have discussed prostaglandin analogs with an eye-care professional.